The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis

Thrombosis and Haemostasis

Volumn 91, Issue 1, 2004, Pages 76-79

  Köppel, Herwig ^a   Renner, Wilfried ^a   Gugl, Alexander ^a   Cichocki, Lisa ^a   Gasser, Robert ^a   Wascher, Thomas C ^a   Pilger, Ernst ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Angiotensin converting enzyme; Genetics; Polymorphism; Venous thromboembolism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 1642475073     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-05-0266     Document Type: Article

References (17)

1. Vaughn DE. The renin-angiotensin system and fibrinolysis. Am J Cardiol 1997; 79: 12-6.
2. Chabielska E, Pawlak R, Buczko W. Effects of drugs affecting the renin-angiotensin system on venous thrombosis in normotensive rats. Pol J Pharmacol 1996; 48: 89-91.
3. Pawlak R, Chabielska E, Buczko W. Antithrombotic effect of enalapril, an angiotensin-converting enzyme inhibitor, on venous thrombosis in rats. Pol J Pharmacol 1996; 48: 117-20.
4. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiogensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
5. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
6. Philipp CS, Dilley A, Saidi P, et al. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 1998; 80: 869-73.
7. Dilley A, Austin H, El-Jamil M, et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 2000; 183: 1271-7.
8. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998; 147: 30-5.
9. Jackson A, Brown K, Langdown J, et al. Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 2000; 111: 562-4.
10. Della Valle CJ MD, Issack PS, Baitner A, et al. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC Musculoskelet Disord 2001; 2: 1.
11. Gonzalez Ordonez AJ, Fernandez Carreira JM, Medina Rodriguez JM, et al. Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. Blood Coagul Fibrinolysis 2000; 11: 485-90.
12. Renner W, Koppel H, Hoffmann C, et al. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 2000; 99: 35-9.
13. Friedl W, Krempler F, Paulweber B, et al. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995; 112: 137-43.
14. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 856-72.
15. Ioannidis JPA, Trikalinos TA, Ntzani EE, et al. Genetic associations in large versus small studies: An empirical assessment. Lancet 2003; 361: 567-71.
16. Fatini C, Gensini F, Sticchi E, et al. ACE DD genotype: An independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003; 33(8): 642-7.
17. Von Depka M, Czawalinna A, Wermes C, et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003; 89(5):847-52.